MREO
Mereo BioPharma Group PLC ADR
NASDAQ: MREO · HEALTHCARE · BIOTECHNOLOGY
$0.27
-2.89% today
Updated 2026-04-30
Market cap
$44.72M
P/E ratio
—
P/S ratio
89.45x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$0 – $3
Volume
1.6M
Mereo BioPharma Group PLC ADR (MREO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $107.30M | $86.76M | $96.34M | $67.28M | $114.52M | $86.08M | $170.96M | $77.41M | $66.50M | $76.39M |
| Cash & equivalents | $79.68M | $53.58M | $50.04M | $25.04M | $20.93M | $31.35M | $126.75M | $68.18M | $57.42M | $69.80M |
| Current assets | $81.28M | $60.78M | $63.18M | $34.50M | $40.32M | $40.65M | $134.32M | $75.20M | $63.76M | $74.76M |
| Total liabilities | $5.76M | $7.51M | $33.85M | $34.51M | $61.19M | $106.55M | $51.95M | $26.01M | $15.96M | $15.42M |
| Current liabilities | $2.82M | $3.21M | $9.62M | $16.18M | $39.58M | $11.71M | $16.96M | $24.38M | $9.49M | $13.85M |
| Long-term debt | $0.00 | $3.13M | $18.81M | $14.65M | $5.37M | $16.14M | $14.38M | — | $4.39M | — |
| Shareholder equity | $101.54M | $79.26M | $62.48M | $32.77M | $53.33M | $-20.47M | $119.01M | $51.40M | $50.54M | $60.97M |
| Retained earnings | $-12.19M | $-33.58M | $-79.32M | $-111.22M | $-193.49M | $-423.51M | $-401.60M | $-404.57M | $-419.63M | $-462.88M |
| Accounts receivable | $297338.00 | $6.10M | $509350.00 | $5.89M | $11.98M | $1.02M | $1.42M | $2.75M | $3.73M | $3.25M |
| Inventory | $0.00 | $-53.92M | $-2.50M | $-293328.00 | $-11.98M | $-4.64M | $-1.82M | $-2.67M | $1.25M | — |
| Goodwill | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |